Blar i Publikasjoner fra CRIStin på forfatter "Abdelnour, Carla"

Viser treff 1-4 av 4

    • Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia 

      Gonzalez Velez, Maria Camila; Tovar-Rios, Diego Alejandro; Alves, Guido Werner; Dalen, Ingvild; Williams-Gray, Caroline H.; Camacho, Marta; Forsgren, Lars; Bäckström, David; Lawson, Rachael A.; Macleod, Angus D.; Counsell, Carl E.; Paquet, Claire; DeLena, Carlo; D'Antonio, Fabrizia; Pilotto, Andrea; Padovani, Alessandro; Blanc, Frédéric; Falup-Pecurariu, Cristian; Lewis, Simon J.G.; Rejdak, Konrad; Papuc, Ewa; Hort, Jakub; Nedelska, Zuzana; O'Brien, John; Bonanni, Laura; Marquié, Marta; Boada, Mercè; Pytel, Vanesa; Abdelnour, Carla; Alcolea, Daniel; Beyer, Katrin; Tysnes, Ole-Bjørn; Aarsland, Dag; Maple-Grødem, Jodi (Peer reviewed; Journal article, 2023)
      Background There is a need to better understand the rate of cognitive and motor decline of Dementia with Lewy bodies (DLB) and Parkinson's disease Dementia (PDD). Objectives To compare the rate of cognitive and motor ...

    • The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies 

      Abdelnour, Carla; Ferreira, Daniel; Oppedal, Ketil; Cavallin, Lena; Bousiges, Olivier; Wahlund, Lars Olof; Hort, Jakub; Nedelska, Zuzana; Padovani, Alessandro; Pilotto, Andrea; Bonanni, Laura; Kramberger, Milica Gregoric; Boada, Mercè; Westman, Eric; Pagonabarraga, Javier; Kulisevsky, Jaime; Blanc, Frédéric; Aarsland, Dag (Peer reviewed; Journal article, 2020-07)
      Background Alzheimer’s disease (AD)-related pathology is frequently found in patients with dementia with Lewy bodies (DLB). However, it is unknown how amyloid-β and tau-related pathologies influence neurodegeneration in ...

    • Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022 

      Abdelnour, Carla; Gonzalez Velez, Maria Camila; Gibson, Lucy L.; Poston, Kathleen L.; Ballard, Clive; Cummings, Jeffrey L.; Aarsland, Dag (Peer reviewed; Journal article, 2023)
      Introduction Reviews of randomized clinical trials (RCTs) in dementia with Lewy bodies (DLB) are essential for informing ongoing research efforts of symptomatic therapies and potentially disease-modifying therapies ...

    • Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data 

      Abdelnour, Carla; Ferreira, Daniel; van de Beek, Marleen; Cedres, Nira; Oppedal, Ketil; Cavallin, Lena; Blanc, Frédéric; Bousiges, Olivier; Wahlund, Lars-Olof; Pilotto, Andrea; Padovani, Alessandro; Boada, Mercè; Pagonabarraga, Javier; Kulisevsky, Jaime; Aarsland, Dag; Lemstra, Afina W.; Westman, Eric (Peer reviewed; Journal article, 2022)
      Background Dementia with Lewy bodies (DLB) includes various core clinical features that result in different phenotypes. In addition, Alzheimer’s disease (AD) and cerebrovascular pathologies are common in DLB. All this ...